BD (Becton, Dickinson and Company) and Ypsomed recently expanded their collaboration to develop a 5.5 mL BD Neopak XtraFlow Glass Prefillable Syringe compatible with Ypsomed's YpsoMate 5.5 ...
BD and Ypsomed will expand their collaboration through the development of a 5.5 ml version of BD’s Neopak XtraFlow glass ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the ...
TORONTO, April 8, 2025 /PRNewswire/ - AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced a new pipeline program in collaboration with a leading global ...
News-Medical.Net on MSN
New CHEST guidelines offer evidence-based biologic selection for severe asthma
The American College of Chest Physicians ® (CHEST) recently released a new clinical guideline on biologic management in severe asthma. Published in the journal CHEST ® , the guideline contains seven ...
Although biologics are usually given by injection or intravenous infusion, oral formulations might be possible. In general, oral drugs offer many benefits, from simplified distribution to overall cost ...
Zacks Investment Research on MSN
BD and Ypsomed expand partnership to target growing biologics market
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results